About Phytoceuticals
Phytoceuticals was founded in 2015 and is based in Adliswil, Switzerland. Operations focus on the production of wound healing products within the phytoceuticals sector, which involves plant-derived therapeutic solutions. Manufacturing processes are centered on developing and supplying these specialized medical items for healthcare applications. Leadership is provided by CEO Gudmundur Fertram Sigurjonsson, with activities conducted primarily in the European market.
- Headquarter Adliswil, Switzerland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Phytoceuticals
Detailed funding history for Phytoceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Phytoceuticals
Phytoceuticals has secured backing from 1 investor. Prominent investors backing the company include Kerecis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Fish-skin acellular dermal matrix technology is provided for wound treatments.
|
Locked | Locked | Locked |
Investor details for Phytoceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Phytoceuticals
Investment portfolio details for Phytoceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Phytoceuticals
Detailed financials for Phytoceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Phytoceuticals Comparisons
Peer comparison for Phytoceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Phytoceuticals
Detailed competitors of Phytoceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Phytoceuticals
Complete news archive for Phytoceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Phytoceuticals
Phytoceuticals was founded in 2015.
Phytoceuticals is headquartered in Adliswil, Switzerland. It is registered at Adliswil, Zurich, Switzerland.
Gudmundur Fertram Sigurjonsson is the current CEO of Phytoceuticals.
Phytoceuticals was founded in 2015 and is based in Adliswil, Switzerland. Operations focus on the production of wound healing products within the phytoceuticals sector, which involves plant-derived therapeutic solutions. Manufacturing processes are centered on developing and supplying these specialized medical items for healthcare applications. Leadership is provided by CEO Gudmundur Fertram Sigurjonsson, with activities conducted primarily in the European market.
Phytoceuticals has 1 investor. Key investors include Kerecis.